-
AGC Biologics to Acquire Novartis Facility in Longmont, CO
contractpharma
July 05, 2021
AGC Biologics, a CDMO, signed a purchase agreement for Novartis’ state-of-the-art Cell and Gene Therapy commercial manufacturing facility in Longmont, CO.
-
Chemomab and AGC Biologics Partner to Manufacture CM-101 for Phase II/III
contractpharma
June 25, 2021
AGC Biologics will manufacture the clinical trial materials at its site in Copenhagen to support clinical testing and launch readiness.
-
AGC Biologics Inks Supply Deal for COVID-19 Vaccine
contractpharma
June 08, 2021
CDMO’s Heidelberg facility to supply plasmid DNA for Pfizer/BioNTech COVID-19 vaccine.
-
AGC Biologics and Oculis Enter Manufacturing Deal
contractpharma
May 08, 2021
AGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), has entered a partnership with Oculis to manufacture OCS-02, a Phase II investigational drug targeting both Dry Eye Disease and Anterior Uveitis ...
-
AGC Biologics Expands Partnership with Rocket Pharmaceuticals
contractpharma
April 22, 2021
AGG will bolster supply across Rocket’s lentiviral vector (LVV) pipeline, with the manufacture of LVV.
-
AGC Biologics Announces the Expansion of Their Cell and Gene Therapy Facility in Milan, Italy
prnasia
March 04, 2021
AGC Biologics announced plans for the expansion of their Cell and Gene Therapy Center of Excellence in Milan, to increase capacities and implement viral vector suspension capabilities.
-
AGC Biologics Appoints Boulder Site GM
contractpharma
January 25, 2021
David Stewart to oversee the startup, strategic development and operational excellence in large-scale biologics production at the Boulder, CO site.
-
AGC Biologics Appoints New Chief Technical Officer
contractpharma
June 12, 2019
Kasper Møller most recently served as site head for AGC’s Copenhagen facility.
-
AGC Biologics Appoints GM
contractpharma
May 16, 2019
Holt will provide leadership and site management for the company’s Bothell, WA ops.
-
AGC Biologics CEO to Step Down
contractpharma
April 09, 2019
AGC Biologics CEO to Step Down